Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of a Wakefulness-Promoting Agent (Armodafinil) Combined With Neuro-rehabilitation to Improve Neurological Recovery and to Reduce the Incidence of Disability in Patients Who Suffered a Stroke

NCT01896128 is registered in ClinicalTrials.gov with Burke Rehabilitation Hospital as lead sponsor.

NCT NCT01896128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01896128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of a Wakefulness-Promoting Agent (Armodafinil) Combined With Neuro-rehabilitation to Improve Neurological Recovery and to Reduce the Incidence of Disability in Patients Who Suffered a Stroke
Lead sponsor
Burke Rehabilitation Hospital
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
July 31, 2015
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident, hemiparesis, stroke